Lincolnshire, IL – Despite an announcement today that Robbins Umeda LLP has filed a class action suit against BioSante Pharmaceuticals (NASDAQ: BPAX) stemming from recent disappointments in its Phase III test results for its revolutionary LibiGel treatment for diminished sexual desire in post menopausal women, the company’s stock has rebounded sharply closing today at...










